Abstract
Saygin et al. discuss the clinical significance of cancer stem cells (CSCs) and results of potential CSC-targeting therapies in various cancers. They highlight barriers to translating cues from pre-clinical models into clinical applications and propose new strategies for rational design of future anti-CSC trials.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 25-40 |
| Number of pages | 16 |
| Journal | Cell Stem Cell |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 3 2019 |
Keywords
- cancer stem cell
- CD123
- differentiation therapies
- hedgehog
- niche
- Notch
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology
Fingerprint
Dive into the research topics of 'Targeting Cancer Stemness in the Clinic: From Hype to Hope'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS